Back to News
Market Impact: 0.3

Canaccord Genuity Maintains Stride (LRN) Buy Recommendation

LRNIJRIVZJHGNDAQ
Analyst EstimatesAnalyst InsightsCorporate EarningsCompany FundamentalsInvestor Sentiment & PositioningMarket Technicals & FlowsFutures & Options
Canaccord Genuity Maintains Stride (LRN) Buy Recommendation

Canaccord Genuity maintained a Buy rating on Stride (NYSE:LRN), setting an average one-year price target of $170.13, which implies an 11.78% upside from its current $152.20. This positive analyst view comes despite a projected 8.79% decrease in annual revenue to $2,194MM and a bearish put/call ratio of 1.02. Institutional sentiment appears mixed, with an increase in the number of funds holding LRN and a higher average portfolio weight, yet total institutional shares owned decreased by 0.99% in the last quarter.

Analysis

Canaccord Genuity maintained a Buy recommendation for Stride (NYSE:LRN) on October 24, 2025, with an average one-year price target of $170.13. This target implies an 11.78% upside from the latest closing price of $152.20/share, despite a projected annual revenue decrease of 8.79% to $2,194 million and a non-GAAP EPS forecast of $4.58. The analyst's positive outlook contrasts with the anticipated top-line contraction. Institutional sentiment shows mixed signals; while the number of funds holding LRN increased by 8.78% to 991 and the average portfolio weight dedicated to LRN rose by 10.93% to 0.30%, total shares owned by institutions decreased by 0.99% to 60,464K in the last quarter. Individual institutional actions also varied, with Invesco increasing shares but significantly decreasing portfolio allocation, while IJR and American Century increased both shares and allocation. Further complicating the picture, the put/call ratio for LRN stands at 1.02, indicating a bearish outlook among options traders. This options market sentiment diverges from the maintained Buy rating and the implied price upside, suggesting potential caution despite the analyst's conviction.

AllMind AI Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Request a Demo